Results 101 to 110 of about 32,801 (227)

Initial Development toward Non-Invasive Drug Monitoring via Untargeted Mass Spectrometric Analysis of Human Skin. [PDF]

open access: yes, 2019
Drug monitoring is crucial for providing accurate and effective care; however, current methods (e.g., blood draws) are inconvenient and unpleasant. We aim to develop a non-invasive method for the detection and monitoring of drugs via human skin.
Bouslimani, Amina   +9 more
core   +1 more source

Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder. [PDF]

open access: yes, 2015
RATIONALE: Obsessive-compulsive disorder (OCD) implicates dysfunction of orbitofrontal and insula-related circuitry and of the serotonin system. There is an on-going search in psychiatry for intermediate biological markers, termed 'endophenotypes', that ...
Chamberlain, Samuel R   +4 more
core   +2 more sources

Effect of treatments for depression on quality of life: a meta-analysis [PDF]

open access: yes, 2017
Published in final edited form as: Cogn Behav Ther. 2017 June; 46(4): 265–286. doi:10.1080/16506073.2017.1304445.Cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are the two first-line treatments for depression, but ...
Carpenter, Joseph K.   +3 more
core   +1 more source

Learnings from familial visual snow syndrome: A case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Visual snow syndrome is a neurological condition defined by the core symptom of visual snow and various additional visual and nonvisual symptoms. It can be of significant impact for affected individuals and treatment is currently challenging. Following an index patient reporting a clustering of visual snow syndrome in his family, we identified
Laura Weichsel   +8 more
wiley   +1 more source

A multidisciplinary, AI‐supported quality improvement intervention to manage polypharmacy in aging people with HIV

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Aging people with HIV are increasingly affected by multimorbidity and polypharmacy, which heighten the risk of drug–drug interactions (DDIs) and potentially inappropriate medications (PIMs). This study evaluated a multidisciplinary, AI‐supported quality improvement intervention designed to optimize polypharmacy management in older ...
Jovana Milic   +13 more
wiley   +1 more source

Escitalopram-induced severe akathisia leading to suicide attempt

open access: yesIndustrial Psychiatry Journal, 2019
Akathisia, a distressing adverse reaction, is usually underdiagnosed or misdiagnosed in patients, who are treated with selective serotonin reuptake inhibitors (SSRIs). Escitalopram-induced akathisia is rarely reported in the literature.
Alok Pratap   +3 more
doaj   +1 more source

Complete Skin Remission of Lichen Planus With Tirzepatide

open access: yes
Australasian Journal of Dermatology, EarlyView.
Harmeet Bhullar   +4 more
wiley   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Effects of Agomelatine on Sleep Across Populations: A Systematic Review and Meta‐Analysis

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Agomelatine, a melatoninergic antidepressant, is often prescribed to improve sleep disturbance, though meta‐analytic evidence is currently lacking. This systematic review and meta‐analysis assessed its efficacy and tolerability in sleep outcomes compared to placebo.
Anastasios Stefanou   +7 more
wiley   +1 more source

Escitalopram-induced hyponatremia

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2017
Escitalopram is an antidepressant belonging to the class of selective serotonin reuptake inhibitors. It is effective in the treatment of generalized anxiety and major depressive disorders.
Anjana Thomas   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy